What are the key filing and response deadlines related to the lawsuit, and how might they affect short‑term trading activity?

Key filing and response dates

- Complaint filing: The Pomerantz‑filed class‑action complaint was lodged on September 3 2025 (the date of the press release).

- Company answer deadline: Under the Federal Rules of Civil Procedure, RxSight must serve its formal answer within 21 days of service of the complaint (or 30 days if a motion for extension is filed). Assuming standard service, the “answer‑by” date falls around September 24–27 2025.

- Class‑certification and settlement‑negotiation windows: The court‑ordered schedule for a motion to certify the class and for any settlement‑offer discussions typically begins 45–60 days after the answer is filed. That pushes the first major litigation‑related catalyst into early‑mid‑October 2025.

Trading implications

The short‑term market will react most sharply to the answer‑deadline. A defensive filing (denial of liability, request for dismissal) often triggers a sell‑off, especially for a stock already under negative sentiment (the alert shows a –70 sentiment score). Traders should watch for volume spikes and price breaks below recent support (≈ $2.10–$2.30) as investors price in the risk of a prolonged litigation battle. Conversely, if the company’s response is unusually conciliatory or quickly offers a settlement, the stock could bounce on the prospect of a quicker resolution. Technical momentum around the deadline (e.g., a breakout above the 20‑day EMA or a breakdown below the 50‑day EMA) can be used as a trigger for short‑term entries or exits.

In practice, a tight‑range, high‑volatility play is appropriate: consider a short‑term bear‑put spread or a tight‑stop‑loss long position if the price cracks the key support before the September 24–27 answer date. Keep an eye on any court filings or Pomerantz updates in the days leading up to the deadline—those releases typically move the stock more than the underlying fundamentals.